| Year | 2023 | 2022 |
|---|---|---|
| CF from Operating Activities | 10.42B | 8.38B |
| Net Income | 5.1B | 4.73B |
| Depreciation & Amortization | 4.26B | 3.59B |
| Deferred Income Taxes | 0 | 149M |
| Stock Based Compensation | 5M | 236M |
| Change in Working Capital | 1.81B | -41M |
| Accounts Receivable | 867M | 69M |
| Inventory | 1.15B | -1.53B |
| Accounts Payable | -1.03B | 2.02B |
| Other Working Capital | 826M | -598M |
| Other Non-Cash Items | -756M | -259M |
| CF from Investing Activities | 10.42B | 8.38B |
| Investments in Property, Plant & Equipment | -4.92B | -5.33B |
| Net Acquisitions | -5.53B | -182M |
| Investment Purchases | -40.51B | -27.84B |
| Sales/Maturities of Investments | 45.16B | 25.93B |
| Other Investing Activites | 848M | 540M |
| CF from Financing Activities | -5.52B | -3.4B |
| Debt Repayment | -4.36B | -2.58B |
| Common Stock Issued | 0 | 0 |
| Common Stock Repurchased | 0 | 0 |
| Dividends Paid | -503M | -401M |
| Other Financing Activites | -656M | -420M |
| Free Cash Flow | 5.31B | 3.05B |
| Operating Cash Flow | 10.42B | 8.38B |
| Capital Expenditures | -4.92B | -5.33B |
| Cash at Beginning of Period | 895M | 2.59B |
| Cash at End of Period | 857M | 721M |
| Net Change In Cash | -38M | -1.87B |
Syngene International Limited
SYNGENE.NS
NSE
701.8INR10.1 (-0.49%)
SYNGENE.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 29.73B | 25.78B |
| Net Income | 5.1B | 4.64B |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -503M | -401M |
| Retained Earnings | 34.36B | 29.73B |
| Other Distributions | 4.13B | 3.54B |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 36.25B | 27.77B |
| Annual Depreciation | 4.26B | 3.6B |
| Capital Expenditure | -4.92B | -5.33B |
| Net PPE | 36.91B | 29.51B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 0 | 0 |
| Goodwill (Previous Year) | 0 | 0 |
| Goodwill | 0 | 0 |